eMed® is the leader in Population Health GLP-1 program and chronic care management related to obesity and type 2 diabetes. eMed Empathetic AI™ Population Health Platform reduces the cost of your baseline GLP-1 program by up to 80% and enables auditable ROI through cost avoidance and improved population health. eMed guarantees participant adherence, reduces costly ancillary medical services, and lowers medication spend. The program provides instant access to live care with no appointments ever.
Our team is over 100 strong. We combine experience from a multitude of domain areas across leading healthcare services. This combination gives us a special edge to drive clinical excellence. It is also why our technology will continue to expand to various use cases that address a broader range of conditions, making healthcare accessible and affordable for both consumers and enterprises.